Who Paid My Doc
Anthony Forrest
Chiropractor Indianapolis, IN Doctor of Osteopathy
NPI 1447511621 CMS profile 1031023
1717 W 86Th St, Suite 470, Indianapolis, IN 46260
General payments
$8,348
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Anthony Forrest of Indianapolis, IN is reported in the CMS Open Payments database as having received $8,348 across 45 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 99th percentile of Chiropractor profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
4 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $456 | 8 | |
| 2024 | General | $362 | 8 | |
| 2023 | General | $767 | 14 | |
| 2022 | General | $6,764 | 15 |
Beside peers
- Anthony Forrest
- Chiropractor median
- Middle half of Chiropractor
- National median
In program year 2025, general payments to Anthony Forrest were reported at $456. Among 1,761 Chiropractor profiles paid that year, the median was $41 and the middle half received between $22 and $119.
Show as a table
| Year | Anthony Forrest | Chiropractor median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $51 | $18–$114 | $163 |
| 2020 | $0 | $31 | $17–$81 | $114 |
| 2021 | $0 | $38 | $19–$119 | $132 |
| 2022 | $6,764 | $47 | $21–$122 | $149 |
| 2023 | $767 | $41 | $21–$125 | $160 |
| 2024 | $362 | $41 | $21–$124 | $164 |
| 2025 | $456 | $41 | $22–$119 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 4 drugsPart D claims
86
Drug cost
$502
Branded share of claims
53.5%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | Brand | 35 | $202 | |
| Oxycodone Hcl | Generic | 27 | $161 | |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | Brand | 11 | $73 | |
| Gabapentin | Generic | 13 | $67 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 30,207 Part D prescribers listed as Student in an Organized Health Care Education/Training Program; they describe a distribution and say nothing about conduct.
Records
45 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Related records
Chiropractor in Indiana
Practitioners in the same specialty and state, ranked by reported value.
All Chiropractor
Everyone recorded under this specialty, nationwide.
Doctors in Indiana
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.